A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder
Clinical trial NCT04100096 · COMPLETED
Trial details
- NCT number
- NCT04100096
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-17
- Primary completion
- 2021-06-27
- Enrollment
- 332
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.